secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001013762-23-003856
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics sets 2023 annual meeting for Nov 29; shareholder proposal deadline Oct 23
--------------------------------------------------------------------------------

- Annual meeting set for November 29, 2023; proxy materials to be delivered around October 23, 2023.
- Rule 14a-8 shareholder proposals must be received by October 23, 2023, at company's Miami Beach office.
- Bylaw director nominations and other proposals due by October 23, 2023.
- Universal proxy rule notices for non-company nominees also due by October 23, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000101376223003856/0001013762-23-003856-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000101376223003856/ea186699-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-003856

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer